These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 19214145

  • 1. Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients.
    Hulin A, Blanchet B, Audard V, Barau C, Furlan V, Durrbach A, Taïeb F, Lang P, Grimbert P, Tod M.
    Ther Drug Monit; 2009 Apr; 31(2):224-32. PubMed ID: 19214145
    [Abstract] [Full Text] [Related]

  • 2. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 3. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Majchrnak J, Gralak B.
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [Abstract] [Full Text] [Related]

  • 4. A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.
    Fleming DH, Mathew BS, Prasanna S, Annapandian VM, John GT.
    Ther Drug Monit; 2011 Apr; 33(2):165-70. PubMed ID: 21383656
    [Abstract] [Full Text] [Related]

  • 5. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ, Nawrocki A, Pescovitz MD, Bouw R, Shaw LM.
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [Abstract] [Full Text] [Related]

  • 6. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
    Weber LT, Hoecker B, Armstrong VW, Oellerich M, Tönshoff B.
    Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
    [Abstract] [Full Text] [Related]

  • 7. A six-hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the Indian subcontinent.
    Fleming DH, Mathew BS, John GT, Chandy SJ, Manivannan J, Jeyaseelan V.
    J Postgrad Med; 2006 Oct; 52(4):248-52. PubMed ID: 17102540
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P, Cremers SC, den Hartigh J, Rijnbeek EM, Ringers J, Lamers CB, van Hoek B.
    Aliment Pharmacol Ther; 2005 Mar 01; 21(5):549-57. PubMed ID: 15740538
    [Abstract] [Full Text] [Related]

  • 12. A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period.
    Mathew BS, Fleming DH, Annapandian VM, Prasanna S, Prasanna CG, Chandy SJ, John GT.
    Ther Drug Monit; 2010 Apr 01; 32(2):136-40. PubMed ID: 20110849
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ther Drug Monit; 2008 Jun 01; 30(3):282-91. PubMed ID: 18520599
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft.
    Neumann I, Fuhrmann H, Kanzler M, Fang IF, Jaeger A, Graf H, Bayer P, Kovarik J.
    Expert Opin Pharmacother; 2008 Apr 01; 9(6):879-86. PubMed ID: 18377332
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of limited sampling strategies for tacrolimus.
    Op den Buijsch RA, van de Plas A, Stolk LM, Christiaans MH, van Hooff JP, Undre NA, van Dieijen-Visser MP, Bekers O.
    Eur J Clin Pharmacol; 2007 Nov 01; 63(11):1039-44. PubMed ID: 17712551
    [Abstract] [Full Text] [Related]

  • 17. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.
    Zhao W, Fakhoury M, Baudouin V, Maisin A, Deschênes G, Jacqz-Aigrain E.
    Ther Drug Monit; 2011 Dec 01; 33(6):681-7. PubMed ID: 22011724
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy.
    Le Guellec C, Büchler M, Giraudeau B, Le Meur Y, Gakoué JE, Lebranchu Y, Marquet P, Paintaud G.
    Eur J Clin Pharmacol; 2002 Jan 01; 57(11):805-11. PubMed ID: 11868803
    [Abstract] [Full Text] [Related]

  • 19. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
    Poulin E, Greanya ED, Partovi N, Shapiro RJ, Al-Khatib M, Ensom MH.
    Ther Drug Monit; 2011 Feb 01; 33(1):50-5. PubMed ID: 21157401
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S, Saint-Marcoux F, Rousseau A, Zhang D, Leroy V, Marquet P, Jacqz-Aigrain E.
    Ther Drug Monit; 2007 Feb 01; 29(1):96-102. PubMed ID: 17304156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.